- Identification of spirocyclic or phosphate substituted quinolizine derivatives as novel HIV-1 integrase inhibitors: a patent evaluation of WO2016094197A1, WO2016094198A1 and WO2016154527A1
- 点击次数：
- 所属单位：药学院
- 发表刊物：Expert Opinion on Therapeutic Patents
- 全部作者：展鹏,刘新泳
- 第一作者：程锡强
- 论文类型：基础研究
- 论文编号：A9472303DA3F4813AA4416BF776CD379
- 卷号： 27
- 期号：11
- 页面范围：1277
- 是否译文：否
- 发表时间：2017-06-01
上一条： Exploiting the Tolerant Region I of the Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Binding Pocket: Discovery of Potent Diarylpyrimidine-Typed HIV-1 NNRTIs against Wild-Type and E138K Mutant Virus with Significantly Improved Water Solubility and Favorable Safety Profiles
下一条： Discovery of uracil-bearing DAPYs derivatives as novel HIV-1 NNRTIs via crystallographic overlay-based molecular hybridization
